Liabilities / Assets
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
990 • Fiscal year 2012 • EIN 48-1209067
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
72nd percentile
Higher net margin than 72% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
66th percentile
Faster asset growth than 66% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Assets
Up$411,593
Up $43,150 (+12%) from 2011
Net Assets
Up$411,593
Up $43,150 (+12%) from 2011
Liabilities
$0
No earlier filing loaded for comparison.
Revenue
Up$288,333
Up $266,718 (+1234%) from 2011
Expenses
Up$245,183
Up $242,078 (+7796%) from 2011
Net Income
Up$43,150
Up $24,640 (+133%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To foster and facilitate international scientific exchange in the pharmaceutical sciences.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.